Article Details

Rentschler Biopharma to produce 100m doses of CureVac vaccine

Retrieved on: 2021-02-02 08:37:30

Tags for this article:

Click the tags to see associated articles and topics

Rentschler Biopharma to produce 100m doses of CureVac vaccine. View article details on hiswai:

Excerpt

by tg. German CDMO Rentschler Biopharma is expanding cCMP production of CureVac NV's RNA-based COVID-19 vaccine candidate CVnCoV.

Article found on: european-biotechnology.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up